Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2003
01/08/2003EP0937088B1 Process for preparing aluminium salts of organic phosphoric acids
01/08/2003EP0923560B1 Bridged and possibly methylolized 4,5-bis-di-hidroxy-imidazolidin-2-ones, process for their production and use thereof
01/08/2003EP0859768B1 Amine acid salt compounds and process for the production thereof
01/08/2003CN1390227A Enzyme catalyzed therapeutic activation
01/08/2003CN1390225A Method for preparing N-phosphono-methyl glycosine
01/08/2003CN1390220A Kinase inhibitors as therapeutic agents
01/08/2003CN1390219A Pyrazolopyrimidines as therapeutic agents
01/08/2003CN1390122A Tissue factor antagonists and methods of use thereof
01/08/2003CN1389467A Method for preparing phosphate
01/08/2003CN1098270C Lithium fluorophosphates and their use as conducting salts
01/08/2003CN1098243C Manufacture of tomato metabolite of carotenoid
01/07/2003US6504049 Process for synthesizing pharmaceutically active disulfide salts
01/07/2003US6504041 Synthesis of ruthenium or osmium metathesis catalysts
01/07/2003US6504025 In fewer steps and is obtained in higher yield; chemical intermediates; useful in treating methicillin resistent Staphylococcus aureus and Pseudomonas aeruginosa
01/07/2003US6503992 For producing television cabinets, computer monitors, related printer housings
01/07/2003US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
01/07/2003CA2192481C Drug salts
01/07/2003CA2087534C Di(2-propyl)esters of 1-fluoro-2-phosphonomethoxy-3-p-toluenesulfonyloxypropanes, their production and utilization
01/07/2003CA2078722C Alkylbisacylphosphine oxides
01/07/2003CA2073737C A process for producing stable, low oder s,s,s-tributylphosphorotrithioate
01/03/2003WO2003000705A1 Novel quinolines and uses thereof
01/03/2003WO2003000704A2 Method for producing n-phosphonomethylglycine
01/03/2003WO2003000703A1 Method for producing n-phosphonomethylglycine
01/03/2003WO2003000702A1 Method for producing $g(a)-aminophosphonic acids
01/03/2003WO2003000701A1 Biomembrane mimetic surface coatings
01/03/2003WO2003000700A2 Ascorbyl derivatives of carnitines and cosmetic compositions containing same
01/03/2003WO2003000270A1 Novel pyridopyrimidones and uses thereof
01/03/2003WO2003000266A1 Novel quinolines and uses thereof
01/03/2003WO2003000251A1 Novel idolinones and uses thereof
01/03/2003WO2003000188A2 Novel quinazolines and uses thereof
01/03/2003WO2003000187A2 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
01/03/2003WO2003000186A2 Novel phenylamino-pyrimidines and uses thereof
01/03/2003WO2003000173A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
01/03/2003WO2002008233A3 Novel phosphorus-containing monomers and flame retardant high impact monovinylidene aromatic polymer compositions derived therefrom
01/03/2003WO2001044260A8 Novel purines
01/03/2003CA2450781A1 Method for producing n-phosphonomethylglycine
01/02/2003US20030004370 Method for production of n-phosphonomethylglycine
01/02/2003US20030004345 Unsaturated phosphonate derivatives of purines and pyrimidines
01/02/2003US20030003526 Compound for use in the measurement of gene expression
01/02/2003EP1270583A1 Process for the purification of phosphonium salts
01/02/2003EP1270582A1 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative
01/02/2003EP1270581A2 Blocked mercaptosilane coupling agents for filled rubbers
01/02/2003EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof
01/02/2003EP1268498A1 Cardioprotective phosphonates and malonates
01/02/2003EP1268497A1 Ternary ligand complexes useful as radiopharmaceuticals
01/02/2003EP1268496A1 Water soluble chiral diphosphines
01/02/2003EP1268495A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
01/02/2003EP1268494A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
01/02/2003EP1268493A1 Phosphoramidate prodrugs
01/02/2003EP1268492A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
01/02/2003EP1268481A2 Kinase inhibitors as therapeutic agents
01/02/2003EP1268096A1 Extrusion die
01/02/2003EP1267835A1 D and l etherlipid stereoisomers and liposomes
01/02/2003EP1267624A2 Methods for enhancing plant health and protecting plants from stress
01/02/2003EP1117670B1 Polymerisation catalysts
01/02/2003EP1015419B1 Polydentate imines and their metal complexes
01/02/2003EP0694030B2 Process to prepare amino carboxylic acid salts
01/01/2003CN1388808A Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same
12/2002
12/31/2002US6500975 Ring opening metathesis polymerization catalysts
12/31/2002US6500917 Process for the preparation of polyether phosphates
12/31/2002US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue
12/31/2002US6500453 Drug delivery
12/31/2002CA2075586C Salicyloyl(thio)ether derivatives, their preparation and intermediates for ther preparation
12/27/2002WO2002102886A1 Phosphorus compounds as stabilizers
12/27/2002WO2002102814A1 Apoptosis inducer
12/27/2002WO2002102813A1 Aryldifluoromethylphosphonic acids for treatment of diabetes
12/27/2002WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002WO2002102766A2 Combretastatin a-3 prodrug
12/27/2002WO2002102509A1 Phosphirene derived catalysts
12/27/2002WO2002083696A3 Novel cyclo azaphospha hydrocarbons
12/27/2002WO2002070662A3 Three hybrid assay system
12/27/2002CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002CA2418102A1 Combretastatin a-3 prodrug
12/26/2002US20020198394 Useful in polymerization reactions, coupling reactions, and other chemical reactions which are facilitated by an appropriate cation
12/26/2002US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity
12/26/2002US20020198171 Administering to a hepatitis B infection patient an effective treatment amount of a 2'fluoro- beta -D-nucleoside or salts(containing purine or pyrimidine base)
12/26/2002US20020197725 Use of infrared spectroscopy for on-line process control and endpoint detection
12/25/2002CN1387534A Phosphites
12/25/2002CN1387510A Process for producing bismuth dithiocarbamates and dithiophosphorates
12/25/2002CN1387460A Double metal cyanide catalysts for producing polyether polyols
12/25/2002CN1386741A Process for synthesizing methylpyridyl phosphide
12/25/2002CN1097060C Method for producing elastomers
12/25/2002CN1097059C Method for producing thermoplastic elastomers
12/25/2002CN1097057C Borate photoinitiators obtained from polyboranes
12/24/2002US6498277 Disulfone reagents and methods of preparing and using same
12/24/2002US6498256 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
12/24/2002US6498196 Thio-aminotetralins; analgesics; opioid receptor affinity; side effect reduction
12/24/2002US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002US6498178 Inhibitors of IMPDH enzyme
12/24/2002US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
12/24/2002US6498150 Low molecular weight cell, bone marrow and immune stimulants
12/24/2002CA2266701C Process for synthesizing carbapenem side chain intermediates
12/23/2002WO2002000670A1 Bisphosphite compounds, the metal complexes thereof and the use of said compounds and complexes in olefin hydroformylation
12/23/2002CA2414123A1 Bisphosphite compounds, their metal complexes and use of the compounds and complexes in the hydroformylation of olefins
12/19/2002WO2002100872A1 Lithium p-diarylphosphinobenzenesulfonates, process for preparation of the same and use thereof
12/19/2002WO2002100871A1 New compounds useful in reflux disease
12/19/2002WO2002100870A1 New napsylate salts ii